Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Metastatic Breast Cancer and Brain Metastases: Exploratory Final Analysis of Cohort 1 From KAMILLA, a Single-Arm Phase IIIb Clinical TrialAnn. Oncol 2020 Jul 04;[EPub Ahead of Print], F Montemurro, S Delaloge, CH Barrios, R Wuerstlein, A Anton, E Brain, T Hatschek, CM Kelly, C Peña-Murillo, M Yilmaz, M Donica, P Ellis
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.